Download PDF
Semin Respir Crit Care Med 2002; 23(2): 155-166
DOI: 10.1055/s-2002-25304
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Pulmonary and Tracheobronchial Amyloidosis

John L. Berk1, 2, 3 , Anthony O'Regan1, 3 , Martha Skinner2, 3
  • 1The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts
  • 2Amyloid Treatment and Research Program, Boston University School of Medicine, Boston, Massachusetts
  • 3Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
Further Information

Publication History

Publication Date:
24 April 2002 (online)

    Permissions and Reprints

ABSTRACT

Amyloidosis is a collection of diseases in which different proteins are deposited as insoluble β-pleated sheets, disrupting organ function. Each precursor protein induces a separate spectrum of organ involvement, and different disease manifestations within the lung. Although autopsy data often demonstrate amyloid deposits in various compartments of the lung, few of the pathologic findings are expressed clinically. We review the pulmonary pathology, radiology, clinical presentations, and treatment options for each of the major systemic and localized forms of amyloidosis. This review focuses on amyloid derived from immunoglobulin light-chain protein (AL disease), which most frequently involves the lung in both systemic and localized forms of the disease. Manifestations of AL-related lung disease range from nodules identified on incidental chest films to diffuse alveolar+-septal deposition mimicking diffuse alveolar damage. We discuss respiratory failure due to diaphragm invasion, proximal tracheal disease, and diffuse alveolar-septal deposition. Guidelines for evaluation of patients with amyloid are presented.

KEYWORD

Amyloidosis - tracheobronchial amyloidosis - lung diseases

REFERENCES

  • 1 Virchow V R. Ueber einem Gehirn und Rueckenmark des Menschen aufgefundene Substanz mit chemischen reaction der Cellulose.  Virchows Arch Pathol Anat . 1854;  6 1358
    PubMedGoogle Scholar
  • 2 Gertz M A. Secondary amyloidosis (AA).  J Intern Med . 1992;  232 517-518
    PubMedGoogle Scholar
  • 3 Celli B R, Rubinow A, Cohen A S, Brody J S. Patterns of pulmonary involvement in systemic amyloidosis.  Chest . 1978;  74 543-547
    CrossrefPubMedGoogle Scholar
  • 4 Smith R R, Hutchins G M, Moore G W, Humphrey R L. Type and distribution of pulmonary parenchymal and vascular amyloid: correlation with cardiac amyloid.  Am J Med . 1979;  66 96-104
    CrossrefPubMedGoogle Scholar
  • 5 Utz J P, Swensen S J, Gertz M A. Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993.  Ann Int Med . 1996;  124 407-413
    PubMedGoogle Scholar
  • 6 Johnson W J, Lie J T. Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association.  Mayo Clin Proc . 1991;  66 919-925
    PubMedGoogle Scholar
  • 7 Livneh A, Langevitz P, Pras M. Pulmonary associations in familial Mediterranean fever.  Curr Opin Pulm Med . 1999;  5 326-331
    CrossrefPubMedGoogle Scholar
  • 8 Westermark P, Sletten K, Johansson B, Cornwell III G G. Fibril in senile systemic amyloidosis is derived from normal transthyretin.  Proc Natl Acad Sci U S A . 1990;  87 2843-2845
    PubMedGoogle Scholar
  • 9 Benson M D. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. New York: McGraw-Hill 2000: 4159-4191
    Google Scholar
  • 10 Jacobson D R, Pastore R, Pool S. Revised transthyretin Ile 122 allele frequency in African-Americans.  Hum Genet . 1996;  98 236-238
    PubMedGoogle Scholar
  • 11 Kunze W P. Senile pulmonary amyloidosis.  Pathol Res Pract . 1979;  164 413-422
    CrossrefPubMedGoogle Scholar
  • 12 Pitkanen P, Westermark P, Cornwell III G G. Senile systemic amyloidosis.  Am J Pathol . 1984;  117 391-399
    PubMedGoogle Scholar
  • 13 Gertz M A, Kyle R A, Thibodeau S N. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period.  Mayo Clin Proc . 1992;  67 428-440
    PubMedGoogle Scholar
  • 14 Simms R W, Prout M N, Cohen A S. The epidemiology of AL and AA amyloidosis.  Baillieres Clin Rheumatol . 1994;  8 627-634
    PubMedGoogle Scholar
  • 15 Falk R H, Comenzo R L, Skinner M. The systemic amyloidoses: current approaches to diagnosis and treatment.  New Engl J Med . 1997;  337 898-909
    CrossrefPubMedGoogle Scholar
  • 16 Berg A M, Troxler R F, Grillone G. Localized amyloidosis of the larynx: evidence for light chain composition.  Ann Otol Rhinol Laryngol . 1993;  102 884-889
    PubMedGoogle Scholar
  • 17 Miura K, Shirasawa H, Lambda III. Subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.  Am J Clin Pathol . 1993;  100 561-566
    PubMedGoogle Scholar
  • 18 Westermark P, Sletten K, Pitkanen P, Natvig J B, Lindholm C E. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.  Mol Immunol . 1982;  19 447-450
    CrossrefPubMedGoogle Scholar
  • 19 Cordier J F, Loire R, Brune J. Amyloidosis of the lower respiratory tract: clinical and pathologic features in a series of 21 patients.  Chest . 1986;  90 827-831
    CrossrefPubMedGoogle Scholar
  • 20 Kyle R A, Gertz M A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases.  Sem Hematol . 1995;  32 45-59
    PubMedGoogle Scholar
  • 21 Road J D, Jacques J, Sparling J R. Diffuse alveolar septal amyloidosis presenting with recurrent hemoptysis and medial dissection of pulmonary arteries.  Am Rev Resp Dis . 1985;  132 1368-1370
    PubMedGoogle Scholar
  • 22 Cools F J, Kockx M M, Boeckxstaens G E, Heuvel P V, Cuykens J J. Primary systemic amyloidosis complicated by massive thrombosis.  Chest . 1996;  110 282-284
    PubMedGoogle Scholar
  • 23 Liu Y Y, Lee Y C, Chou T Y, Perng R P. Pulmonary alveolar-septal amyloidosis presenting as heart failure with unilateral pleural effusion: a case report.  Chung Hua I Hsueh Tsa Chih (Taipei) . 1999;  62 838-843
    PubMedGoogle Scholar
  • 24 Strange C, Heffner J E, Collins B S, Brown F M, Sahn S A. Pulmonary hemorrhage and air embolism complicating transbronchial biopsy in pulmonary amyloidosis.  Chest . 1987;  92 367-369
    PubMedGoogle Scholar
  • 25 Hui A N, Koss M N, Hochholzer L, Wehunt W D. Amyloidosis presenting in the lower respiratory tract: clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases.  Arch Pathol Lab Med . 1986;  110 212-218
    PubMedGoogle Scholar
  • 26 Kyle R A, Bayrd E D. Amyloidosis: review of 236 cases.  Medicine (Baltimore) . 1975;  54 271-299
    PubMedGoogle Scholar
  • 27 Rakhit R D, Clesham G J, Cleland J G. Sarcoid, amyloid and heart failure.  Int J Cardiol . 1993;  41 180-182
    CrossrefPubMedGoogle Scholar
  • 28 Rainfray M, Meyrier A, Valeyre D, Tazi A, Battesti J P. Renal amyloidosis complicating sarcoidosis.  Thorax . 1988;  43 422-423
    PubMedGoogle Scholar
  • 29 Sharma O P, Koss M, Buck F. Sarcoidosis and amyloidosis: is the association causal or co-incidental?.  Sarcoidosis . 1987;  4 139-141
    PubMedGoogle Scholar
  • 30 Smith F B, Brown R B, Maguire G, Oliver J. Localized pleural microdeposition of type A amyloid in a patient with rheumatoid pleuritis: histologic distinction from pleural involvement in systemic amyloidosis.  Am J Clin Pathol . 1993;  99 261-264
    PubMedGoogle Scholar
  • 31 Knapp M J, Roggli V L, Kim J, Moore J O, Shelburne J D. Pleural amyloidosis.  Arch Pathol Lab Med . 1988;  112 57-60
    PubMedGoogle Scholar
  • 32 Kavuru M S, Adamo J P, Muzaffar A, Mehta A C, Gephardt G N. Amyloidosis and pleural disease.  Chest . 1990;  98 20-23
    PubMedGoogle Scholar
  • 33 Lundin P, Simonsson B, Winberg T. Pneumopleural amyloid tumor.  Acta Radiol . 1961;  55 139-144
    PubMedGoogle Scholar
  • 34 Keane J, Vosburgh E, O'Regan A, Falk R, Berk J L. Recurrent symptomatic pleural effusion in patients with AL amyloidosis: a marker of concomitant pleural disease.  Am J Respir Crit Care Med . 1998;  157 A741.
    PubMedGoogle Scholar
  • 35 Graham D R, Ahmad D. Amyloidosis with pleural involvement.  Eur Respir J . 1988;  1 571-572
    PubMedGoogle Scholar
  • 36 Bontemps F, Tillie-Leblond I, Coppin M C. Pleural amyloidosis: thoracoscopic aspects.  Eur Respir J . 1995;  8 1025-1027
    PubMedGoogle Scholar
  • 37 Ikeda S, Takabayashi Y, Maejima Y. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis.  Amyloid . 1999;  6 292-296
    PubMedGoogle Scholar
  • 38 Streeten E A, de la Monte M S, Kennedy T P. Amyloid infiltration of the diaphragm as a cause of respiratory failure.  Chest . 1986;  89 760-762
    CrossrefPubMedGoogle Scholar
  • 39 Santiago R M, Scharnhorst D, Ratkin G, Crouch E C. Respiratory muscle weakness and ventilatory failure in AL amyloidosis with muscular pseudohypertrophy.  Am J Med . 1987;  83 175-178
    CrossrefPubMedGoogle Scholar
  • 40 Pickford H A, Swensen S J, Utz J P. Thoracic cross-sectional imaging of amyloidosis.  Am J Roentgenol . 1997;  168 351-355
    PubMedGoogle Scholar
  • 41 Graham C M, Stern E J, Finkbeiner W E, Webb W R. High-resolution CT appearance of diffuse alveolar septal amyloidosis.  Am J Roentgenol . 1992;  158 265-267
    PubMedGoogle Scholar
  • 42 Gross B H. Radiographic manifestations of lymph node involvement in amyloidosis.  Radiology . 1981;  138 11-14
    CrossrefPubMedGoogle Scholar
  • 43 Fukuda T, Takao M, Uchida T, Iwanaga S, Hayashi K, Okimoto T. High attenuation lymphadenopathy caused by amyloidosis.  Br J Radiol . 1997;  70 213-214
    PubMedGoogle Scholar
  • 44 Desai R A, Mahajan V K, Benjamin S, Van Ordstrand S H, Cordasco E M. Pulmonary amyloidoma and hilar adenopathy: rare manifestations of primary amyloidosis.  Chest . 1979;  76 170-173
    PubMedGoogle Scholar
  • 45 Thompson P J, Citron K M. Amyloid and the lower respiratory tract.  Thorax . 1983;  38 84-87
    CrossrefPubMedGoogle Scholar
  • 46 Rubinow A, Celli B R, Cohen A S, Rigden B G, Brody J S. Localized amyloidosis of the lower respiratory tract.  Am Rev Resp Dis . 1978;  118 603-611
    PubMedGoogle Scholar
  • 47 Ayuso M C, Gilabert R, Bombi J A, Salvador A. CT appearance of localized pulmonary amyloidosis.  J Comput Assist Tomogr . 1987;  11 197-199
    CrossrefPubMedGoogle Scholar
  • 48 Himmelfarb E, Wells S, Rabinowitz J G. The radiologic spectrum of cardiopulmonary amyloidosis.  Chest . 1977;  72 327-332
    CrossrefPubMedGoogle Scholar
  • 49 Diaz-Jimenez J P, Rodriguez A, Ballarin J IM, Castro M J, Argemi T M, Manresa F. Diffuse tracheobronchial amyloidosis.  J Bronchol . 1999;  6 13-17
    PubMedGoogle Scholar
  • 50 O'Regan A, Fenlon H M, Beamis Jr F J, Steele M P, Skinner M, Berk J L. Tracheobronchial amyloidosis: the Boston University experience from 1984 to 1999.  Medicine (Baltimore) . 2000;  79 69-79
    CrossrefPubMedGoogle Scholar
  • 51 Capizzi S A, Betancourt E, Prakash U B. Tracheobronchial amyloidosis.  Mayo Clin Proc . 2000;  75 1148-1152
    CrossrefPubMedGoogle Scholar
  • 52 Crestani B, Monnier A, Kambouchner M, Battesti J P, Reynaud P, Valeyre D. Tracheobronchial amyloidosis with hilar lymphadenopathy associated with a serum monoclonal immunoglobulin.  Eur Respir J . 1993;  6 1569-1571
    PubMedGoogle Scholar
  • 53 Condon R E, Pinkham R D, Hames G H. Primary isolated nodular pulmonary amyloidosis: report of a case.  J Thorac Cardio Surg . 1964;  48 498
    PubMedGoogle Scholar
  • 54 Weiss L. Isolated multiple nodular pulmonary amyloidosis.  Am J Clin Pathol . 1960;  33 318
    PubMedGoogle Scholar
  • 55 Kirchner J, Jacobi V, Kardos P, Kollath J. CT findings in extensive tracheobronchial amyloidosis.  Eur Radiol . 1998;  8 352-354
    CrossrefPubMedGoogle Scholar
  • 56 Skinner M, Anderson J, Simms R. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.  Am J Med . 1996;  100 290-298
    CrossrefPubMedGoogle Scholar
  • 57 Kyle R A, Gertz M A, Greipp P R. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.  N Engl J Med . 1997;  336 1202-1207
    CrossrefPubMedGoogle Scholar
  • 58 Comenzo R L, Vosburgh E, Falk R H. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.  Blood . 1998;  91 3662-3670
    PubMedGoogle Scholar
  • 59 Breuer R, Simpson G T, Rubinow A, Skinner M, Cohen A S. Tracheobronchial amyloidosis: treatment by carbon dioxide laser photoresection.  Thorax . 1985;  40 870-871
    PubMedGoogle Scholar
  • 60 Flemming A F, Fairfax A J, Arnold A G, Lane D J. Treatment of endobronchial amyloidosis by intermittent bronchoscopic resection.  Brit J Dis Chest . 1980;  74 183-188
    PubMedGoogle Scholar
  • 61 Thompson P J, Ryan G, Laurence B H. Laser photoradiation therapy for tracheobronchial amyloid.  Austra New Zeal J Med . 1986;  16 229-230
    PubMedGoogle Scholar
  • 62 Yap J C, Wang Y T, Poh S C. A case of primary diffuse tracheobronchial amyloidosis treated by laser therapy.  Sing Med J . 1992;  33 198-200
    PubMedGoogle Scholar
  • 63 Shapiro S J, Shapiro S D, Mill W B, Campbell E J. Prospective study of long-term pulmonary manifestations of mantle irradiation.  Int J Radiat Oncol Biol Phys . 1990;  19 707-714
    PubMedGoogle Scholar
  • 64 Kurrus J A, Hayes J K, Hoidal J R, Menendez M M, Elstad M R. Radiation therapy for tracheobronchial amyloidosis.  Chest . 1998;  114 1489-1492
    PubMedGoogle Scholar
  • 65 Shinoi K, Shirai-Shi U, Yahata J. Amyloid tumor of the trachea and lung resembling bronchial asthma.  Dis Chest . 1962;  42 442-445
    PubMedGoogle Scholar
  • 66 Rajan K G, Reynolds S P, McConnochie K, White J P. Localised amyloid-presenting as bronchial asthma.  Eur J Respir Dis . 1987;  71 213-215
    PubMedGoogle Scholar
  • 67 McDonald D R, Brunden K R, Landreth G E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.  J Neurosci . 1997;  17 2284-2294
    PubMedGoogle Scholar
  • 68 Tennent G A, Lovat L B, Pepys M B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.  Proc Natl Acad Sci U S A . 1995;  92 4299-4303
    PubMedGoogle Scholar